Corporate News 08-Aug-19
Astrazeneca Pharma India appoints director
With effect from 30 September 2019
Astrazeneca Pharma India has appointed Narayan K Seshadri (DIN: 00053563) as Independent Director for a 2nd term of 5 years i.e., with effect from 30 September 2019 to 29 September 2024.
Previous News
Astrazeneca Pharma India to declare Quarterly Result
( Corporate News - 27-Jan-24 12:06 )
Astrazeneca Pharma India to declare Quarterly Result
( Corporate News - 20-May-22 14:17 )
Astrazeneca Pharma India standalone net profit rises 96.78% in the June 2022 quarter
( Results - Announcements 08-Aug-22 14:55 )
AstraZeneca receives DCGI approval for launch of Olaparib Film-Coated tablets in India
( Corporate News - 19-Aug-22 19:06 )
AstraZeneca Pharma gets CDSCO nod for Dapagliflozin tablets
( Hot Pursuit - 28-Nov-22 10:12 )
Astrazeneca Pharma India to announce Quarterly Result
( Corporate News - 01-Nov-22 10:34 )
Astrazeneca Pharma India standalone net profit rises 236.78% in the June 2019 quarter
( Results - Announcements 07-Aug-19 16:27 )
Vivimed Labs Ltd Spikes 12.07%
( Hot Pursuit - 07-Feb-19 09:30 )
AstraZeneca Pharma India hits 52-week low
( Hot Pursuit - 18-Feb-22 14:51 )
Astrazeneca Pharma India standalone net profit rises 57.94% in the September 2019 quarter
( Results - Announcements 11-Nov-19 16:51 )
Astrazeneca Pharma India to hold board meeting
( Corporate News - 19-May-21 09:45 )
Other Stories
ITD Cementation India wins order of Rs 1,937 cr
03-Oct-24 10:35
NIIT Learning Systems allots 1,666 equity shares under ESOP
03-Oct-24 10:30
Ashoka Metcast to discuss results
03-Oct-24 10:29
Emerald Finance to declare Quarterly Result
03-Oct-24 10:29
Rhetan TMT schedules board meeting
03-Oct-24 10:29
Shrenik to table results
03-Oct-24 10:29
Universal Arts to declare Quarterly Result
03-Oct-24 10:28
Three M Paper Boards to conduct board meeting
03-Oct-24 10:28
Arkade Developers to declare Quarterly Result
03-Oct-24 10:28
Worth Investment & Trading Company announces board meeting date
03-Oct-24 10:28
Back
Top
